FDA panel votes 5-3 in favor of Abbott's Mitraclip benefits, WSJ says

theflyonthewall.com

An FDA advisory panel unanimously said Abbott Laboratories' (ABT) Mitraclip heart device was safe, but voted 5-4 against the question of if there is a "reasonable assurance" the product is effective, while voting 5-3 in support of the device's benefits outweighing the risks, according to a Wall Street Journal report.

View Comments (0)